SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Theragenics (TGX) on the up and up -- Ignore unavailable to you. Want to Upgrade?

To: seedy who wrote (964)7/9/1998 10:57:00 PM
From: Martin Savitska  Respond to of 1055
 
Mike (seedy),

Thanks for the very informative response. Looks like THRX and (NASI,
INIS, NYE) are "twin sons of different mothers". Both PD-103 and
I-125 are used for prostate cancer. One used for hot, one used for slow. Too bad Dain and Cabot couldn't, wouldn't, and didn't analyze
the difference between the two seeds before making a blanketed sell
signal. Neither one of them appears to have the focus or attention
span of a nat(sp). IMO, seeding is just in its' infancy and can only
expand from here. Out patient, non-evasive techniques is the future.

Regards, Marty



To: seedy who wrote (964)7/10/1998 11:58:00 AM
From: Tulvio Durand  Read Replies (3) | Respond to of 1055
 
Could seeds be used for treating other prostate problems, viz., to alleviate BPH and prostatitis symptoms? While irradiated seeds reduce the size of tumors, do they also reduce the prostate gland size as well? Tulvio


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News